ATXN1 and Ataxia: Eliminating mutant ATXN1 in all neurons with Nestin-Cre substantially delayed ataxia onset and extended lifespan, indicating the central nervous system as the primary driver of disease, while striatal-restricted deletion using Rgs9-Cre had minimal impact, suggesting a lesser contribution of striatal neurons at early stages [13].